サンプル依頼リスト カート
表紙：臨床検査サービスの世界市場：第10版
市場調査レポート
商品コード
1785094

臨床検査サービスの世界市場：第10版

Worldwide Market for Clinical Laboratory Services, 10th Edition

出版日
ページ情報
英文 270 pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
臨床検査サービスの世界市場：第10版
出版日: 2025年08月06日
発行: Kalorama Information
ページ情報: 英文 270 pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

"臨床検査サービスの世界市場 第10版"は、世界の臨床検査サービス産業の決定的な分析を提供し、2024年から2029年までの市場規模、成長促進要因、需要のある検査タイプ、競合のポジショニングに関する競合考察を提供します。当レポートは、COVID-19の流行状態への移行に伴う診断サービスのダイナミクスを理解しようとする利害関係者にとって重要な資料となります。

IVDメーカーにとって当レポートが不可欠な理由

Kalorama Informationによるこの年次レビューは、体外診断用医薬品メーカーにとって不可欠です。臨床検査室は体外診断薬（IVD）市場の中核であり、遺伝病や感染症から慢性疾患や腫瘍に至るまで、幅広い疾患の診断、モニタリング、治療に不可欠な知見を提供しています。臨床診断の70～80%はラボ検査によるものであり、これらのサービスは現代のヘルスケア提供に不可欠です。

ラボサービスの市場機会 第10版

当レポートの第10版では、世界の検査需要を形成している開発に焦点を当て、臨床検査の現状を詳細に評価しています。過去の市場動向から現在および予測データまで、当レポートは企業が業績をベンチマークし、将来のシフトに備えるのに役立ちます。

当レポートの主な特徴

  • 業界の概要：歴史的ルーツ、ヘルスケアにおける役割の進化、外来および遠隔検査への依存の高まりなど、臨床検査部門を詳細に解説。
  • 影響力のある統計：人口動態の変化、疾病の発生動向、平均寿命、臨床検査業界に影響を与える広範なヘルスケア環境を分析。
  • 世界的フォーカス：地域別内訳
    • 北米（米国、カナダ）
    • EMEA（ドイツ、フランス、イタリア、スペイン、英国、スイス）
    • アジア太平洋（日本、中国、インド、韓国、オーストラリア）
    • ラテンアメリカ（ブラジル、メキシコ）

対象となる専門分野

  • 必須およびルーチン検査：臨床化学、血液学、凝固学、内分泌学
  • 免疫学および微生物学検査
  • 細胞学および組織学検査
  • 遺伝子検査
  • 毒物学検査（乱用薬物）
  • COVID-19検査

試験所タイプ別市場セグメンテーション

  • 独立系検査機関および基準検査機関
  • 病院ベースの検査室
  • クリニックベースの検査機関

競合分析：

当レポートでは、臨床検査サービスプロバイダー各社の市場戦略、地域別の強み、医療提供モデルや償還構造の変化に対応した調整について詳述し、包括的な競合レビューを掲載しています。

データと予測
基準年 2024年
過去データ 2019年～2024年
予測期間 2025年～2029年
CAGR： すべての主要セグメントについて提供
市場レベル サービスプロバイダー/メーカーレベルの収益

課題と調整：

価格圧力、償還制度改革、統合動向、COVID-19の継続的な影響など、業界の新たな動向を反映するため、当レポートの各版は改訂されています。また、在宅医療や外来医療への依存の高まりなど、診断サービスに対する新たな需要パターンを促進する業務シフトも考慮しています。

除外項目

当レポートでは、臨床試験検査、動物用ラボ、環境検査、検体採取や輸送などの付帯サービスによる収益は除外しています。

目次

調査会社について

第1章 エグゼクティブサマリー

第2章 業界概要

  • 臨床検査の説明
  • 国別臨床検査従事者数
  • 最大の臨床検査市場：米国
  • 研究所開発試験規則
  • 支払者と償還
  • 価格の透明性
  • 消費者向け直接検査
  • がん検査の活用と技術の拡大
  • 情報技術の役割
  • 業界の促進要因

第3章 専門分野別の検査サービス

  • 検査とサービスの概要
  • 臨床化学- 日常検査と必須検査
  • 免疫学と微生物学
  • 細胞診および組織診検査
  • 遺伝子検査
  • 毒性試験

第4章 プロバイダーグループ別世界臨床検査市場

  • 臨床検査市場：プロバイダー概要
  • 病院および急性期ケア提供者
  • 医師と外来診療提供者
  • 独立系検査機関

第5章 北米市場

  • 概要
  • 米国
  • CLIA検査室登録、種類別検査室
  • 米国の病院データ
  • カナダ

第6章 欧州、中東・アフリカ（EMEA）市場

  • 概要
  • 主要市場
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • スイス

第7章 アジア太平洋市場

  • 概要
  • 主要国
    • 日本
    • 日本の臨床検査業界の構造
    • 中国
    • 中国の臨床検査産業構造
    • インド
    • オーストラリア
    • 韓国

第8章 ラテンアメリカ市場

  • 概要
  • 主要国
    • ブラジル
    • メキシコ

第9章 主要市場参入企業

  • 世界競合企業サマリー
  • 企業プロファイル
  • ARUP LABORATORIES
  • BIOREFERENCE HEALTH - AN OPKO HEALTH SUBSIDIARY
  • DAVITA
  • EUROFINS SCIENTIFIC SE
  • EXACT SCIENCES CORP.
  • GUARDANT HEALTH
  • H.U. GROUP HOLDINGS
  • LABORATORY CORPORATION OF AMERICA
  • MEDICOVER AB
  • MYRIAD GENETICS, INC.
  • NATERA
  • QUEST DIAGNOSTICS, INC.
  • SIEMENS HEALTHINEERS
  • SONIC HEALTHCARE LIMITED
  • SYNLAB INTERNATIONAL GMBH
  • UNILABS

第10章 市場動向とサマリー

  • 世界市場概要
  • 地域概要
    • 人口増加
    • 高齢化社会
    • 疾病負担の増大
    • 発展途上地域の経済成長
    • 先進地域における経済の安定化
    • 価格圧力
    • 効率的な医療システムに焦点を当てる
    • ヘルスケアサービスの需要の全体的な増加
    • COVID-19
    • マルチプレックス検査
    • AIと機械学習の研究室の動向
    • 分子検査やその他の高度な検査が新たな道を開く
    • デジタル病理学の動向
    • 人員不足
目次
Product Code: 25-034KA

"Worldwide Market for Clinical Laboratory Services, 10th Edition" provides a definitive analysis of the global clinical lab services industry, offering critical insights into market size, growth drivers, testing types in demand, and competitive positioning from 2024 to 2029. This report is a key resource for stakeholders seeking to understand diagnostic service dynamics in the wake of COVID-19's transition to endemic status.

Why This Report is Essential for IVD Manufacturers

This annual review by Kalorama Information is indispensable for IVD manufacturers. Clinical laboratories are the core of the in vitro diagnostics (IVD) market, delivering essential insights for diagnosis, monitoring, and treatment across a wide range of conditions-from genetic and infectious diseases to chronic illnesses and oncology. With 70-80% of clinical diagnoses informed by lab tests, these services remain integral to modern healthcare delivery.

Market Opportunity in Lab Services: Now in Its 10th Edition

The 10th edition of this report offers an in-depth assessment of the clinical laboratory landscape, highlighting developments that are shaping global testing demand. From historical market trends to current and forecasted data, the report helps companies benchmark performance and prepare for future shifts.

Key Features of the Report:

  • Industry Overview: Presents a detailed exploration of the clinical laboratory sector, including its historical roots, evolving role in healthcare, and the growing reliance on outpatient and remote testing.
  • Influential Statistics: Analyzes demographic shifts, disease incidence trends, life expectancy, and the broader healthcare environment impacting the clinical lab industry.
  • Global Focus: Regional breakdowns include:
    • North America (United States, Canada)
    • EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland)
    • Asia Pacific (Japan, China, India, South Korea, Australia)
    • Latin America (Brazil, Mexico)

Specialty Segments Covered:

  • Essential and Routine Testing: Clinical chemistry, hematology, coagulation, and endocrinology
  • Immunology and Microbiology Testing
  • Cytology and Histology Testing
  • Genetic Testing
  • Toxicology Testing (Drugs of Abuse)
  • COVID-19 Testing

Market Segmentation by Laboratory Type:

  • Independent and Reference Laboratories
  • Hospital-based Laboratories
  • Clinic-based Laboratories

Competitive Analysis:

The report includes a comprehensive competitive review of top clinical laboratory service providers, detailing their market strategies, regional strengths, and adjustments in response to shifting healthcare delivery models and reimbursement structures.

Data and Forecasting
    Base Year:          2024
    Historical Data:          2019-2024
    Forecast Period:          2025-2029
    CAGRs:          Provided for all major segments
    Market Level:          Service provider/manufacturer level revenues

Challenges and Adjustments:

Each edition of the report is revised to reflect new industry developments, including pricing pressures, reimbursement reform, consolidation trends, and the continued impact of COVID-19. It also considers operational shifts such as increased reliance on home-based and outpatient care settings, driving new demand patterns for diagnostic services.

Exclusions:

The report excludes revenues from clinical trial testing, veterinary labs, environmental testing, and ancillary services such as specimen collection and transportation.

TABLE OF CONTENTS

ABOUT KALORAMA INFORMATION

CHAPTER ONE: EXECUTIVE SUMMARY

  • INDUSTRY AT A GLANCE
    • Figure 1-1: Worldwide Market for Clinical Laboratory Services Snapshot, 2025 (Market Overview, Key Service Providers, World Regions)
  • SCOPE AND METHODOLOGY
  • GLOBAL MARKET OVERVIEW
    • Figure 1-2: Factors Growing Clinical Lab Demands, 2025
    • Table 1-1: Global Clinical Laboratory Market Analysis, 2019-2029 ($ million)
    • Figure 1-3: Global Clinical Laboratory Market Analysis, 2019-2029 ($ million)
  • KEY ISSUES AND TRENDS AFFECTING THE MARKET
  • LEADING MARKET PARTICIPANTS

CHAPTER TWO: INDUSTRY OVERVIEW

  • CLINICAL LABORATORY DESCRIPTION
    • Figure 2-1: Clinical Labatory Order
    • Figure 2-2: Hospital Length of Stay in Days, by Country, 2021 Average (Australia, Austria, Belgium, Canada, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Luxembourg, the Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States)
    • Laboratory Service Payer Types
      • Table 2-1: U.S. Clinical Laboratory Revenues, by Client and Payer Type, 2024 (%) (Commercial Insurance, Managed Care, Medicare and Medicaid, Private Patient)
      • Figure 2-3: Clinical Laboratory Revenues, by Client and Payer Type, Estimated 2024 (%) (Commercial Insurance, Managed Care, Medicare and Medicaid, Private Patient)
  • NUMBER OF LABORATORY HEALTH WORKERS BY COUNTRY
    • Figure 2-4: Laboratory Health Workers, by Country, 2010-2021 Average (Argentina, Australia, Brazil, Canada, China, India, Indonesia, Mexico, Republic of Korea, South Africa, United Kingdom, United States)
  • THE LARGEST CLINICAL LABORATORY MARKET: THE UNITED STATES
    • Structure and Regulation in the U.S.
    • Certificate of Waiver
      • Table 2-2: Selected CLIA Waived Laboratory Tests
    • Certificate of Provider-Performed Microscopy Procedures (PPMP)
      • Table 2-3: Provider-Performed Microscopy Procedures
    • Certificate of Compliance and Certificate of Accreditation
      • Figure 2-5: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), April 2024 (%)
      • Table 2-4: Clinical Laboratory Certificates Issued, by State and by Type (non-exempt laboratories only), as of April 2024
      • Figure 2-6: Laboratory Certificate Trends, by Application Type, July 2010-April 2024 (Accreditation, Compliance, PPM, Waiver)
    • States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
      • Table 2-5: CLIA Exempt States, Number of Laboratories, as of April 2024
  • LABORATORY DEVELOPED TEST REGULATIONS
    • Directive 2017/746 (IVDR)
  • PAYERS AND REIMBURSEMENT
    • Figure 2-7: Positive Forces and Negative Forces Impacting Clinical Laboratory Services, 2025
    • Trends in Medicare Reimbursement
      • Figure 2-8: Medicare Reimbursement Trends, Average Reimbursement for Clinical Laboratory Services, 2009 through 2024
    • Protecting Access to Medicare Act (PAMA) of 2014
      • Table 2-6: Proposed Clinical Diagnostic Laboratory Test Rates, 2020-2026
    • Saving Access to Laboratory Service Act (SALSA)
    • Advanced Laboratory Tests (ADLT)
      • Table 2-7: List of Approved ADLTs, March 2025
    • Bundled Insurance Payments for ESRD Patients
      • Table 2-8: Laboratory Tests Subject to ESRD Consolidated Billing (CY 2025)
    • Commercial Insurance Providers
      • Table 2-9: National Commercial Insurance Provider List Revenues, 2024
      • Figure 2-9: National Commercial Insurance Providers by Membership and Total Revenues, 2024 ($ billion)
  • TRANSPARENCY IN PRICING
    • Figure 2-10: Revenue and Test Volume Trends, Quest Diagnostics, 2010-2024 ($ million) (volume million)
  • DIRECT-TO-CONSUMER TESTING
    • Table 2-10: Select DTC Tests and Prices by Laboratory Service Provider (Quest Direct and Labcorp On Demand), 2023 (US $)
  • EXPANDING CANCER TEST UTILIZATION AND TECHNOLOGIES
    • Labcorp Acquires Select Assets of Invitae
    • Labcorp Launches Plasma Detect
    • Quest Launches MelaNodal Predict Test
    • Labcorp Launches First CDx Assay for Gastric Cancer Patients
    • Labcorp Expands Molecular Residual Disease and Liquid Biopsy Solutions
    • Quest Develops Multi-Cancer Stratification Blood Test
  • THE ROLE OF INFORMATION TECHNOLOGY
    • Table 2-11: Selected Laboratory Information Management System Providers, 2024 Vendor List
  • INDUSTRY DRIVERS
    • Global Demographics
      • Table 2-12: The Global Population, 1980-2060 (millions)
      • Figure 2-11: The Global Population, 1980-2060 (millions)
    • Regional Population Overview
      • Table 2-13: World Population by UN Defined Geographic Region, 2010-2060 (millions)
      • Figure 2-12: World Population by UN Defined Geographic Region, 2010-2060 (millions)
    • Aging Populations
      • Table 2-14: Global Population Trends Age 65+, 2000-2060 (millions)
      • Figure 2-13: Global Population Trends Age 65+, 2000-2060 (millions)
    • Chronic Diseases and Conditions
      • Figure 2-14: Global Prevalence of Disease, 2000, 2015, and Projected 2030
      • Figure 2-15: Leading Causes of Death Globally, by Number of Deaths, 2021 (millions)
    • Economic Performance
    • Health Expenditures
      • Figure 2-16: Global Health Spending as a Percentage of GDP, by Country, 2023 estimates (%) (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, the Netherlands, Poland, Russia, South Korea, Saudi Arabia, South Africa, Spain, Turkey, United Kingdom, United States)
    • Laboratory Performance Drivers and Challenges
    • Drivers
    • Challenges

CHAPTER THREE: TESTING SERVICES BY SPECIALTY

  • TEST AND SERVICES OVERVIEW
    • Figure 3-1: Global Clinical Laboratory Market Analysis: Service Revenue Trend, 2019-2029 ($ million)
    • Table 3-1: Global Clinical Laboratory Market Analysis, by Test Segment, 2019-2029 ($ million)* (Clinical Chemistry: Routine & Essential; COVID-19; Cytology & Histology; Genetic; Immunology & Microbiology; Toxicology)
    • Figure 3-2: Global Clinical Laboratory Market Analysis, by Test Segment, 2019-2029 ($ million)* (Clinical Chemistry: Routine & Essential; COVID-19; Cytology & Histology; Genetic; Immunology & Microbiology; Toxicology)
    • Figure 3-3: Global Clinical Laboratory Market Analysis, Segment Growth Forecast, CAGR 2024-2029 (%) (Clinical Chemistry: Routine & Essential; COVID-19; Cytology & Histology; Genetic; Immunology & Microbiology; Toxicology)
    • Figure 3-4: Global Clinical Laboratory Market Analysis, by Testing Service, Distribution of Revenues, 2024 (%) (Clinical Chemistry: Routine & Essential; COVID-19; Cytology & Histology; Genetic; Immunology & Microbiology; Toxicology)
  • CLINICAL CHEMISTRY - ROUTINE AND ESSENTIAL TESTING
    • Figure 3-5: Global Clinical Laboratory Market Analysis: Clinical Chemistry - Routine & Essential Testing Service Market Trend, 2019-2029 ($ million)
    • Table 3-2: Market Overview - Routine and Essential Testing, by Service Segment, 2024 ($ million) (Clinical Chemistry, Coagulation, Endocrinology, Hematology, Others)
    • Figure 3-6: Market Revenue - Routine and Essential Testing, by Service Segment, 2024 ($ million) (Clinical Chemistry, Coagulation, Endocrinology, Hematology, Others)
    • Figure 3-7: Market Share - Routine and Essential Testing, by Service Segment, 2024 (%) (Clinical Chemistry, Coagulation, Endocrinology, Hematology, Others)
    • Routine Clinical Chemistry
    • Cholesterol Level Testing
      • Table 3-3: High Cholesterol Risk Categories
    • Urinalysis
      • Table 3-4: Normal Reference Levels in a Medical Urinalysis
    • Hematology
    • Blood Cell Count
      • Table 3-5: Laboratory Reference Parameters for CBC
    • Coagulation
    • Endocrinology
    • Thyroid Function Tests
    • Pregnancy Testing
      • Table 3-6: hCG Levels in Pregnant Women by Days Past Ovulation
  • IMMUNOLOGY AND MICROBIOLOGY
    • Figure 3-8: Global Clinical Laboratory Market Analysis: Immunology & Microbiology Testing Service Market Trend, 2019-2029 ($ million)
    • Table 3-7: Market Overview - Immunology & Microbiology Testing, by Service Segment, 2024 ($ million) (Immunology, Infectious Disease)
    • Figure 3-9: Market Revenue - Immunology & Microbiology Testing, by Service Segment, 2024 ($ million) (Immunology, Infectious Disease)
    • Figure 3-10: Market Share - Immunology & Microbiology Testing, by Service Segment, 2024 ($ million) (Immunology, Infectious Disease)
    • Allergy and Food Intolerance
    • Tumor Markers
    • Cardiac Markers
    • HIV Testing
  • CYTOLOGY AND HISTOLOGY TESTING
    • Figure 3-11: Global Clinical Laboratory Market Analysis: Cytology & Histology Testing Service Market Trend, 2019-2029 ($ million)
    • Table 3-8: Market Overview - Cytology & Histology Testing, by Service Segment, 2024 ($ million) (HPV Testing (Routine/DNA), Tumor Pathology)
    • Figure 3-12: Market Revenue - Cytology & Histology Testing, by Service Segment, 2024 ($ million) (HPV Testing (Routine/DNA), Tumor Pathology)
    • Figure 3-13: Market Share - Cytology & Histology Testing, by Service Segment, 2024 ($ million) (HPV Testing (Routine/DNA), Tumor Pathology)
    • Pap Test
      • Figure 3-14: Percent of Females Aged 20-69 Screened for Cervical Cancer (all screening methods), by Select Country, 2019 Estimates (%) (Canada, China, France, Germany, Hungary, India, Israel, Italy, Japan, The Netherlands, Poland, Romania, Saudi Arabia, South Africa, South Korea, Spain, Turkey, United Kingdom, United States)
      • Figure 3-15: Summary Recommendations: WHO Suggests Using the Following Strategy for Cervical Cancer Prevention, 2021
  • GENETIC TESTING
    • Figure 3-16: Global Clinical Laboratory Market Analysis: Genetic Testing Service Market Trend, 2019-2029 ($ million)
    • Table 3-9: Market Overview - Genetic Testing, by Service Segment, 2024 ($ million) (Prenatal/Newborn Screening, Other Genetic Screening)
    • Figure 3-17: Market Revenue - Genetic Testing, by Service Segment, 2024 ($ million) (Prenatal/Newborn Screening, Other Genetic Screening)
    • Figure 3-18: Market Share - Genetic Testing, by Service Segment, 2024 ($ million) (Prenatal/Newborn Screening, Other Genetic Screening)
  • TOXICOLOGY TESTING
    • Figure 3-19: Global Clinical Laboratory Market Analysis: Toxicology Testing Service Market Trend, 2019-2029 ($ million)
    • Table 3-10: Substance Detection Periods, by Selected Test Method

CHAPTER FOUR: GLOBAL CLINICAL LABORATORY MARKET BY PROVIDER GROUP

  • CLINICAL LABORATORY MARKET: PROVIDER OVERVIEW
    • Table 4-1: Global Clinical Laboratory Market Analysis, by Provider Segment, 2024 and 2029 (Hospitals, Independent, Physician Offices/Outpatient Clinics)
    • Figure 4-1: Global Clinical Laboratory Market Analysis: Provider Segment Growth Forecast, CAGR 2024-2029 (%) (Hospitals, Independent, Physician Offices/Outpatient Clinics)
    • Figure 4-2: Global Clinical Laboratory Market Analysis by Provider Group, Distribution of Revenues, 2024 (%) (Hospitals, Independent, Physician Offices/Outpatient Clinics)
  • HOSPITALS AND ACUTE CARE PROVIDERS
    • Figure 4-3: COVID-19 Impact on Hospital-based Laboratory Testing Markets, 2022-2024 ($ million)
    • Table 4-2: Global Clinical Laboratory Market Analysis: Hospital and Acute Care Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
    • Figure 4-4: Global Clinical Laboratory Market Analysis: Hospital and Acute Care Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
    • Figure 4-5: Hospital Beds per 1,000 Population, by Country, 2023/2024 (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, The Netherland, Poland, Russia, Saudi Arabia, South Africa, South Korea, Spain, Turkey, United Kingdom, United States)
    • Figure 4-6: Global Visualization - Hospital Beds per 1,000 Population, by Country, 2023/2024
  • PHYSICIANS AND OUTPATIENT CARE PROVIDERS
    • Figure 4-7: COVID-19 Impact on Physician-based Laboratory Testing Markets, 2022-2024 ($ million)
    • Table 4-3: Global Clinical Laboratory Market Analysis: Physician and Outpatient Care Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
    • Figure 4-8: Global Clinical Laboratory Market Analysis: Physician and Outpatient Care Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
    • Physician Offices
      • Figure 4-9: Medical Doctors per 1,000 Population, by Country, 2023/2024 (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, The Netherland, Poland, Russia, Saudi Arabia, South Africa, South Korea, Spain, Turkey, United Kingdom, United States)
      • Figure 4-10: Global Visualization - Medical Doctors per 1,000 Population, by Country, 2023/2024
    • Global Nursing Establishments and Assisted Living Facilities
    • Global Dialysis Clinics
  • INDEPENDENT LABORATORY PROVIDERS
    • Figure 4-11: COVID-19 Impact on Independent Laboratory Testing Markets, 2022-2024 ($ million)
    • Table 4-4: Revenues for Selected U.S.-based Reference Labs, 2019-2024 ($ million)* (Bio-Reference Lab/OPKO, Labcorp, Quest Diagnostics)
    • Table 4-5: Estimated Clinical Test Volume, by Select Independent Laboratory, 2024 (millions of units) (Bio-Reference Lab/Opko, Eurofins Scientific, Labcorp, Medicover, Natera, NeoGenomics, Quest Diagnostics, Sonic Healthcare, Unilabs)
    • Table 4-6: Global Clinical Laboratory Market Analysis: Independent Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)
    • Figure 4-12: Global Clinical Laboratory Market Analysis: Independent Laboratory Testing Market, 2024-2029 ($ million) (U.S./International Estimates)

CHAPTER FIVE: NORTH AMERICA MARKET

  • OVERVIEW
    • Table 5-1: North America Market Value, by Country, 2024 ($ million)* (United States, Canada & other regions)
    • Figure 5-1: North America Clinical Laboratory Service Revenues, by Country, 2024-2029 ($ million)* (Canada and United States)
    • Figure 5-2: North America Clinical Laboratory Service Share, by Country, 2024 (%) (United States, Canada & other regions)
  • UNITED STATES
    • Table 5-2: United States Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Figure 5-3: United States Clinical Laboratory Service Market Performance, 2019-2029 ($ million)
    • U.S. Market by Test Type
      • Table 5-3: United States Clinical Laboratory Service Market, by Testing Service Type, Estimates and Forecast 2024-2029 ($ million) (COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology)
      • Figure 5-4: United States Clinical Laboratory Market Analysis: Testing Service Revenues Over Time, by Testing Service Type, 2019-2029 ($ million) (COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology)
      • Figure 5-5: United States Clinical Laboratory Market Analysis: Testing Service Revenue Share, by Testing Service Type, 2024 ($ million) (COVID-19, Cytology & Pathology, Essential & Routine, Genetic, Immunology & Microbiology, Toxicology)
    • U.S. Market by Laboratory Provider Type
      • Table 5-4: United States Clinical Laboratory Service Market, by Laboratory Type, Estimates and Forecast 2024-2029 ($ million) (Hospital-based, Independent, Physician-based)
      • Figure 5-6: United States Clinical Laboratory Market Analysis: Testing Service Revenues Over Time, by Laboratory Type, 2019-2029 ($ million) (Hospital-based, Independent, Physician-based)
      • Figure 5-7: United States Clinical Laboratory Market Share, by Laboratory Type, 2024 (%) (Hospital-based, Independent, Physician-based)
    • U.S. Clinical Laboratory Industry Structure
      • Figure 5-8: Growth in Clinical Laboratories, 2000-2024
  • CLIA Laboratory Registration, Laboratories by Type
    • Figure 5-9: U.S. CLIA Clinical Laboratory Registration, by Primary Laboratory Type, May 2024
    • Table 5-5: CLIA Registered Laboratories, by Type of Facility (Exempt/Non-Exempt Combined), May 2024
    • Figure 5-10: Growth Trends in CLIA Registered Laboratories, by Type of Facility (Exempt/Non-Exempt Combined) June 2020 and May 2024
    • Figure 5-11: Percent Change in CLIA Registered Laboratories by Type of Facility, Highest and Lowest Growth Segments, Compounded Annually, 2020-2024 (%)
    • Independent Clinical Laboratories
      • Figure 5-12: Leading U.S. Independent Laboratory Groups, Distribution of Centers, December 2024 (%)
    • Growth in Independent Clinical Laboratories
      • Figure 5-13: Growth in U.S. Independent Laboratory Facilities, June 2011 through April 2024
    • Hospital-based Laboratories
  • U.S. Hospital Data
    • Table 5-6: U.S. Hospital Types
    • Table 5-7: AHA Statistics - U.S. Registered Hospitals, by Type, 2010-2023
    • Table 5-8: AHA Statistics for U.S. Hospitals, 2014-2023
    • U.S. Hospital Stay Stats
      • Figure 5-14: U.S. Hospital Length of Stay, Average by Broad Age Group, 2021 (# days of hospital stay)
    • Growth in Hospital Clinical Laboratories
      • Figure 5-15: Growth in U.S. Hospital Laboratory Locations, June 2011-April 2024
    • Physician-Office and Clinic Laboratories
    • Number of U.S. Physicians
    • Growth in Clinical Laboratories in Physician Offices
      • Figure 5-16: Growth in U.S. Physician Office Laboratory Locations, June 2011-April 2024
    • Nursing Facility and Home Health
    • U.S. Nursing Home Establishments
    • U.S. Home Health Facilities
    • Growth in Clinical Laboratories in the Nursing Facility and Home Health Segment
      • Figure 5-17: Growth in U.S. Nursing Facility/Home Health Laboratory Locations, June 2011-April 2024
    • Pharmacy-based Laboratories
    • Growth in Pharmacy-Based Clinical Laboratories
      • Figure 5-18: Growth in U.S. Pharmacy-Based Laboratories, mid-2011-April 2024
    • Dialysis Clinics
    • Growth in U.S. Dialysis Clinics and Affiliated Laboratories
      • Figure 5-19: Growth in U.S. Dialysis Clinic-based Laboratories, mid-2011-April 2024
  • CANADA
    • Table 5-9: Canada Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Figure 5-20: Canada Clinical Laboratory Service Market, Performance 2019-2029 ($ million)

CHAPTER SIX: EUROPE, THE MIDDLE EAST, AND AFRICA (EMEA) MARKET

  • OVERVIEW
    • Table 6-1: EMEA Market Value, by Country, 2024 ($ million)* (France, Germany, Italy, Spain, Switzerland, United Kingdom, Rest of EMEA)
    • Figure 6-1: EMEA Clinical Laboratory Service Market Value, by Country, 2024-2029 ($ million)* (France, Germany, Italy, Spain, Switzerland, United Kingdom)
    • Figure 6-2: EMEA Clinical Laboratory Service Market Share, by Country, 2024 (%) (France, Germany, Italy, Spain, Switzerland, United Kingdom, Rest of EMEA)
    • Figure 6-3: EMEA Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2024-2029 (%) (France, Germany, Italy, Spain, Switzerland, United Kingdom, Rest of EMEA)
  • KEY MARKETS
    • Germany
      • Table 6-2: Germany Clinical Laboratory Service Market, Estimates and Forecast 2024-2029 ($ million)
      • Figure 6-4: Leading Laboratory Service Suppliers, by Estimated Distribution of Revenues, Germany, 2024 (%) (Eurofins, IMD - Medicover, Siemens, Sonic, SYNLAB, Others)
    • France
      • Table 6-3: France Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Italy
      • Table 6-4: Italy Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Spain
      • Table 6-5: Spain Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • United Kingdom
      • Table 6-6: United Kingdom Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Switzerland
      • Table 6-7: Switzerland Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)

CHAPTER SEVEN: ASIA PACIFIC (APAC) MARKET

  • OVERVIEW
    • Table 7-1: Asia Pacific Clinical Laboratory Service Market Value, by Country, 2024 ($ million) (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
    • Figure 7-1: Asia Pacific Clinical Laboratory Service Market Value, by Country, 2024-2029 ($ million)* (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
    • Figure 7-2: Asia Pacific Clinical Laboratory Service Market Share, by Country, 2024 (%) (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
    • Figure 7-3: Asia Pacific Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2024-2029 (%) (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
  • KEY COUNTRIES
    • Japan
      • Table 7-2: Japan Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Japan Clinical Laboratory Industry Structure
      • Figure 7-4: Japan Clinical Laboratory Industry, by Type, 2024 (%)
      • Figure 7-5: Japan Clinical Laboratory Industry, by Test Classification, 2023-2024 (%) (Basic (essential/routine), Non-Basic, Pathology, Other Test Services)
      • Figure 7-6: Japan Clinical Laboratory Industry, Number of Laboratories by Prefecture, 2024 (%)
    • China
      • Table 7-3: China Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • China Clinical Laboratory Industry Structure
      • Figure 7-7: China Clinical Laboratory Industry, by Type, 2024 (%)
    • India
      • Table 7-4: India Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Australia
      • Table 7-5: Australia Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • South Korea
      • Table 7-6: South Korea Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)

CHAPTER EIGHT: LATIN AMERICA MARKET

  • OVERVIEW
    • Table 8-1: Latin America Clinical Laboratory Service Market Value, by Country, 2024 ($ million) (Brazil, Mexico, Rest of Latin America)
    • Figure 8-1: Latin America Clinical Laboratory Service Market Value, by Country, 2024-2029 ($ million)* (Brazil, Mexico, Rest of Latin America)
    • Figure 8-2: Latin America Clinical Laboratory Service Market Share, by Country, 2024 (%) (Brazil, Mexico, Rest of Latin America)
    • Figure 8-3: Latin America Clinical Laboratory Service Market, Growth Projections, by Country, CAGR 2024-2029 (%) (Brazil, Mexico, Rest of Latin America)
  • KEY COUNTRIES
    • Brazil
      • Table 8-2: Brazil Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)
    • Mexico
      • Table 8-3: Mexico Clinical Laboratory Service Market, Estimates and Forecast 2024 and 2029 ($ million)

CHAPTER NINE: LEADING MARKET PARTICIPANTS

  • GLOBAL COMPETITOR SUMMARY
    • Figure 9-1: Market Participants, Global Service Revenues, Estimated 2023 and 2024 ($ million)
    • U.S. COMPETITIVE ANALYSIS
      • Table 9-1: Top Ten Estimated U.S. Laboratory Service Revenues ($ million) and Market Share (%) of Leading Clinical Laboratory Providers, 2024
      • Figure 9-2: Top 10 Estimated U.S. Laboratory Services, Market Share of Leading Clinical Laboratory Providers, 2024 (%)
  • SELECT COMPANY PROFILES
  • ARUP LABORATORIES
    • Company Overview
      • Table 9-2: ARUP Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • BIOREFERENCE HEALTH - AN OPKO HEALTH SUBSIDIARY
    • Company Overview
      • Table 9-3: BioReference Health Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • DAVITA
    • Company Overview
      • Table 9-4: DaVita Corporate Details
    • Products and Services
  • EUROFINS SCIENTIFIC SE
    • Company Overview
      • Table 9-5: Eurofins Scientific Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • EXACT SCIENCES CORP.
    • Company Overview
      • Table 9-6: Exact Sciences Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • GUARDANT HEALTH
    • Company Overview
      • Table 9-7: Guardant Health Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • H.U. GROUP HOLDINGS
    • Company Overview
      • Table 9-8: H.U. Group Holdings, Inc. Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • LABORATORY CORPORATION OF AMERICA
    • Company Overview
      • Table 9-9: Laboratory Corporation of America Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • MEDICOVER AB
    • Company Overview
      • Table 9-10: Medicover Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • MYRIAD GENETICS, INC.
    • Company Overview
      • Table 9-11: Myriad Genetics Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • NATERA
    • Company Overview
      • Table 9-12: Natera Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • QUEST DIAGNOSTICS, INC.
    • Company Overview
      • Table 9-13: Quest Diagnostics Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • SIEMENS HEALTHINEERS
    • Company Overview
      • Table 9-14: Siemens Healthineers Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • SONIC HEALTHCARE LIMITED
    • Company Overview
      • Table 9-15: Sonic Healthcare Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • SYNLAB INTERNATIONAL GMBH
    • Company Overview
      • Table 9-16: SYNLAB Corporate Details
    • Key Acquisitions, Alliances, and Partnerships
    • Products and Services
  • UNILABS
    • Company Overview
      • Table 9-17: Unilabs Corporate Details
    • Products and Services

CHAPTER TEN: MARKET TRENDS AND SUMMARY

  • GLOBAL MARKET OVERVIEW
    • Table 10-1: Global Clinical Laboratory Market Analysis, 2019-2029 ($ million)*
    • Figure 10-1: Global Clinical Laboratory Market Analysis, 2019-2029 ($ million)
  • REGIONAL OVERVIEW
    • Table 10-2: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2024 ($ million) (Asia Pacific, EMEA, Latin America, North America)
    • Figure 10-2: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2024 ($ million) (Asia Pacific, EMEA, Latin America, North America)
    • Figure 10-3: Global Clinical Laboratory Service Market Share, Revenues by Region, 2024 (%) (Asia Pacific, EMEA, Latin America, North America)
    • Figure 10-4: Global Clinical Laboratory Market Analysis: Regional Growth Forecast, CAGR 2024-2029 (%) (Asia Pacific, EMEA, Latin America, North America)
    • Population Growth
    • Aging Populations
    • Increasing Disease Burden
    • Economic Growth in Developing Regions
    • Stabilizing Economies in Developed Regions
    • Pricing Pressures
    • Focus on Efficient Health Systems
    • Overall Growth in Demand for Healthcare Services
    • COVID-19
    • Multiplex Testing
    • AI and Machine Learning Laboratory Trends
    • Molecular Testing and Other Advanced Testing Will Open New Avenues
    • Digital Pathology Trends
    • Staffing Shortages